Shannon Eagan, Patrick Gibbs and Tijana Brien from Cooley have stepped in to represent AcelRx Pharmaceuticals Inc., CEO Vincent J. Angotti and CFO Raffi Asadorian in a pending securities class action. The suit, for allegedly false claims about the risks of DSUVIA, medication for the treatment of acute pain, was filed June 8 in California Northern District Court by Pomerantz LLP. The case, assigned to U.S. District Judge Beth Labson Freeman, is 5:21-cv-04353, Sneed v. AcelRx Pharmaceuticals Inc. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

Read the complaint here: